The ASX shrugged off the Fed’s first rate hike since 2023, as banks rallied, goldies slipped and Trump demanded cheaper money.
Following an upbeat healthcare earnings reporting season, RBC Capital Markets has upped its recommendation on a swathe of biotech stocks.
Mount Ridley is doing more with less as latest testing of its trademarked Selectro process delivers higher rare earth and scandium recoveries
Rock chip assays up to 4.3% copper and 1.4g/t gold have helped define a second mineralised direction at Uaroo Ridge.
Professor unpacks the 12-week results from ENP’s treatment-resistant patient study and what they mean for the future potential of TRP-8803.
